|
Aug 7
|
NVAX Stock Gains on Q2 Earnings & Sales Beat, Ups '25 Sales View
|
|
Aug 6
|
Novavax Ups Outlook, Eyes Stronger Nuvaxovid Sales
|
|
Aug 6
|
Novavax lifts 2025 revenue outlook after FDA milestone payment
|
|
Aug 6
|
Novavax banks on vaccine supply partnerships to boost 2025 revenue
|
|
Aug 6
|
Novavax: Q2 Earnings Snapshot
|
|
Aug 6
|
Novavax Reports Second Quarter 2025 Financial Results and Operational Highlights
|
|
Jul 30
|
Novavax (NVAX) Sees a More Significant Dip Than Broader Market: Some Facts to Know
|
|
Jul 30
|
Novavax to Report Second Quarter 2025 Financial Results on August 6, 2025
|
|
Jul 28
|
Here is What to Know Beyond Why Novavax, Inc. (NVAX) is a Trending Stock
|
|
Jul 24
|
Novavax's H5N1 Vaccine Candidate Demonstrates Immunogenicity in Preclinical Study
|
|
Jul 16
|
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
|
|
Jul 14
|
Novavax (NVAX) Rises Higher Than Market: Key Facts
|
|
Jul 13
|
BTIG Maintains a Buy Rating on Novavax (NVAX), Sets a $19 PT
|
|
Jul 11
|
2 Beaten-Down Stocks That Haven't Hit Rock Bottom Yet
|
|
Jul 10
|
Citi Initiates Coverage of Novavax (NVAX) With a Sell Rating
|
|
Jul 1
|
Is Most-Watched Stock Novavax, Inc. (NVAX) Worth Betting on Now?
|
|
Jun 27
|
Novavax (NVAX) Stock Slides as Market Rises: Facts to Know Before You Trade
|
|
Jun 18
|
Roku upgraded, Sarepta downgraded: Wall Street’s top analyst calls
|
|
Jun 12
|
Why Is Fate Therapeutics (FATE) Up 61.5% Since Last Earnings Report?
|
|
Jun 12
|
Novavax's COVID-Flu Combo Shot Shows Strong Immune Response
|